Hunan Warrant Pharmaceutical Co.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 926.99 million compared to CNY 806.31 million a year ago. Revenue was CNY 926.99 million compared to CNY 806.31 million a year ago.

Net income was CNY 124.14 million compared to CNY 103.26 million a year ago. Basic earnings per share from continuing operations was CNY 1.32 compared to CNY 1.1 a year ago. Diluted earnings per share from continuing operations was CNY 1.32 compared to CNY 1.1 a year ago.